Braeburn Pharmaceuticals Inc - Company Review
Braeburn Pharmaceuticals Inc - Company ReviewSummary
Braeburn Pharmaceuticals Inc (Braeburn), a subsidiary of Apple Tree Partners is a pharmaceutical company that develops novel and long-acting implantable and injectable treatments.The company’s product pipeline includes Probuphine, CAM2038, BB-0417, BB-0817, BB-1216. Its Probuphine, is a a six-month subdermal buprenorphine implant for the treatment of opioid addiction. Braeburn offers CAM2038, a weekly and monthly subcutaneous injection depot formulation of buprenorphine for the treatment of opioid addiction and pain. The company’s products are used in the treatment of cental nervous disorders including addiction, schizophrenia and pain. It conducts research in the areas of opioid use disorder, chronic pain, schizophrenia and spasticity. Braeburn is headquartered in Princeton, New Jersey, the US.
This comprehensive company report of Braeburn Pharmaceuticals Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.